Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn's Disease

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02887287

Enrollment

Registered

2016-09-02

Start date

2013-07-31

Completion date

Unknown

Last updated

2016-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Efficacy of Exclusive Enteral Nutrition in Adult Active Crohn's Disease With Complications or Failure of Medical Treatment

Brief summary

The study aimed to prove EEN is effective for inducing early clinical remission, mucosal healing, promoting fistula closure and reducing the size of abscess to adult CD patients. They plan to include about 50 patients and observe the effect of EEN.

Interventions

DRUGEEN

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Inclusion criteria

* \>18 years old * Patients with CD was diagnosed clinically according to previously established international criteria \[9\] * The diagnosis of stricture, fistula and abdominal abscess was confirmed by ultrasound, CT enterography (CTE), and endoscopy. The bowel stricture should mainly cause by inflammation but not fibrosis.

Exclusion criteria

* Patients do not macth the inclusion criteria and those who refuse to taking part in the study

Design outcomes

Primary

Measure	Time frame
Clinical remission after 12 weeks EEN	July 2013 to October 2015

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026